Active Surveillance for Low-Risk Cancers - A Viable Solution to Overtreatment?

N Engl J Med. 2017 Jul 20;377(3):203-206. doi: 10.1056/NEJMp1703787.

Authors

Megan R Haymart¹, David C Miller¹, Sarah T Hawley¹

Affiliation

¹ From the Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine (M.R.H.), the Institute for Healthcare Policy and Innovation (M.R.H., D.C.M., S.T.H.), the Department of Urology (D.C.M.), and the Division of General Medicine, Department of Internal Medicine (S.T.H.), University of Michigan, Ann Arbor.

No abstract available

MeSH terms

Breast Neoplasms / therapy
Female
Humans
Male
Medical Overuse / prevention & control
Neoplasms / therapy*
Prostatic Neoplasms / therapy
Risk
Thyroid Neoplasms / therapy
Watchful Waiting*

Grants and funding